Endometrial Cancer News and Research

RSS

Internal radiotherapy better than external for quality of life in endometrial cancer patients

Quality of life after treatment for endometrial cancer can be significantly improved by the use of vaginal brachytherapy, where radiotherapy is delivered internally using a vaginal cylinder, the European Cancer Conference (ECCO 14) heard today (Monday September 24).

24 Sep 2007

Breast cancer drug tamoxifen helps treat symptoms of bipolar disease

Government researchers in the United States have found that the breast cancer drug tamoxifen helped treat the manic symptoms of bipolar disease.

13 Sep 2007

Tamoxifen for bipolar disorder

The medication tamoxifen, best known as a treatment for breast cancer, dramatically reduces symptoms of the manic phase of bipolar disorder more quickly than many standard medications for the mental illness, a new study shows.

13 Sep 2007

Significant association between alcohol and endometrial cancer in postmenopausal women

Postmenopausal women consuming two or more alcoholic beverages a day may double their risk of endometrial cancer, suggests a study led by researchers at the University of Southern California (USC). The study will appear in the International Journal of Cancer, and is now available online.

10 Sep 2007

Laser technology detects cancer by scanning surface veins

A new technology for cancer detection that eliminates the need for drawing blood has been developed by Purdue University researchers.

5 Sep 2007

Vaginal bleeding a sign of endometrial cancer

Women past menopause who experience any abnormal vaginal bleeding or spotting should contact their physician. It's one of the signs of endometrial cancer.

5 Sep 2007

Obesity and aversion to exercise could enhance the risk of pancreatic cancer

Obesity and aversion to exercise have become hallmarks of modern society and a new study suggests that a blood protein linked to these lifestyle factors may be an indicator for an increased risk of developing pancreatic cancer.

17 Aug 2007

FDA says eating tomatoes does not decrease risk of cancer

A U.S. Food and Drug Administration (FDA) review has found only limited evidence for an association between eating tomatoes and a decreased risk of certain cancers, according to an article published online July 10 in the Journal of the National Cancer Institute.

11 Jul 2007

Researchers find alteration in gene associated with uterine cancer

Researchers at the Translational Genomics Research Institute (TGen) today announced the discovery of previously unrecognized alterations in a gene called FGFR2 in a subset of endometrial cancers, the most common gynecologic cancer in the United States.

24 May 2007

Merits and risks of postmenopausal hormone therapy

The study was categorized as a primary prevention trial for coronary heart disease, although the fact that mean age at recruitment was 63 years was not given enough importance at that time. WHI investigators concluded that hormone therapy (HT) was not cardioprotective, and, in fact, its riskbenefit ratio did not favor the use of postmenopausal hormones for prevention of chronic diseases.

17 May 2007

Women who take hormone replacement therapy are more likely to be diagnosed with ovarian cancer

Results from the Million Women Study, which is the biggest study of its kind in the world, show that over five years there is one extra case of ovarian cancer in every 2,500 women who take HRT. And for every 3,300 women who take HRT, there will be one additional death from ovarian cancer.

20 Apr 2007

Response to paper on ovarian cancer in the Million Women study

The Million Women Study (MWS) has reported new data on the risk of ovarian cancer in postmenopausal hormone users(1).

20 Apr 2007

Study improves understanding of early ovarian cancer

A new University of Michigan Medical School study sheds light on cell defects that lead to one common type of ovarian cancer and puts forth a promising new mouse model that already is being used for preclinical drug testing.

12 Apr 2007

New mouse model for ovarian cancer

12 Apr 2007

Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma

For breast cancer patients taking tamoxifen, switching to an aromatase inhibitor within three years significantly improves survival rates, according to a new study.

12 Feb 2007

Oral contraceptives and IUDs protect against endometrial cancer

According to a new study by researchers in the U.S., oral contraceptives and intrauterine devices (IUD) appear to provide long-term protection against endometrial cancer.

22 Nov 2006

Uterine cancer may be clue to Lynch syndrome

A new study suggests that women with endometrial cancer should be screened for inherited mutations that could lead to a high risk of several other cancers.

2 Aug 2006

Most women at high risk for breast cancer do not increase their life expectancy by taking the drug tamoxifen

Tamoxifen is an extraordinarily expensive cancer-prevention strategy, costing as much as $1.3 million per year of life saved.

24 Jul 2006

Obese women at greater risk of disease and death

Experts say that obesity is a disease that now affects nearly one-third of the adult American population, approximately 60 million people, and the latest study on the condition suggests that health risks to women who are obese may have been underestimated.

6 Jul 2006

Osteoporosis drug Raloxifene shown to be as effective as Tamoxifen in preventing invasive breast cancer

Initial results of the Study of Tamoxifen and Raloxifene, or STAR, show that the drug raloxifene, currently used to prevent and treat osteoporosis in postmenopausal women, works as well as tamoxifen in reducing breast cancer risk for postmenopausal women at increased risk of the disease.

18 Apr 2006